Koninklijke Philips N.V. (PHI1.DE)
XETRA · EUR · Healthcare · Medical Devices
€23.89 (+0.25%) as of
Key statistics
- Market cap
- 23.35B
- P/E (TTM)
- 20.77
- EPS (TTM)
- 1.15
- Dividend yield
- 3.55%
- 52-week range
- 20.92 – 27.57
- Beta
- 0.92
- Revenue (TTM)
- 17.66B
- Profit margin
- 6.31%
- Volume
- 1.36k
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Amsterdam, Netherlands
- Employees
- 63,670
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.